Preoperative transcatheter arterial chemoembolization and prognosis of patients with solitary large hepatocellular carcinomas (≥5 cm): Multicenter retrospective study

Large hepatocellular carcinoma (LHCC) is prone to short‐term recurrence and poor long‐term survival after hepatectomy, and there is still a lack of effective neoadjuvant treatments to improve recurrence‐free survival (RFS) and overall survival (OS). We retrospectively analyzed the efficacy of preoperative transcatheter arterial chemoembolization (TACE) in solitary LHCC (≥5 cm).

[1]  T. Hibi,et al.  The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system , 2021, Journal of hepato-biliary-pancreatic sciences.

[2]  W. Lau,et al.  Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis , 2021, Cancer medicine.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  Xiujun Cai,et al.  Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma , 2020, World journal of gastroenterology.

[5]  Xiaozhen Zhang,et al.  A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[6]  Lequn Li,et al.  Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status , 2019, Annals of medicine.

[7]  T. Pawlik,et al.  Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis , 2019, Hepatology International.

[8]  C. Li,et al.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China , 2019, JAMA surgery.

[9]  Jingxian Shen,et al.  Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence , 2018, Journal of Cancer.

[10]  Neil Mehta,et al.  Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant , 2017, JAMA oncology.

[11]  Jiwei Huang,et al.  Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis , 2017, Scandinavian journal of gastroenterology.

[12]  W. Wentao,et al.  Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma , 2017, Scientific Reports.

[13]  W. Cong,et al.  Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update , 2016, World journal of gastroenterology.

[14]  C. Peng,et al.  Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials , 2016, Scandinavian journal of gastroenterology.

[15]  G. Ko,et al.  Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma , 2016, World Journal of Surgery.

[16]  M. Schwartz,et al.  Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.

[17]  Zhouying Zheng,et al.  Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: A meta‐analysis , 2015, International journal of cancer.

[18]  Lequn Li,et al.  Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma , 2014, Annals of surgery.

[19]  Zi-fang Song,et al.  Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses , 2014, Journal of Cancer Research and Clinical Oncology.

[20]  S. Chuang,et al.  Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: A nationwide Taiwan database analysis of long‐term outcome predictors , 2014, Journal of surgical oncology.

[21]  Y. Maehara,et al.  Beneficial effects of preoperative lipiodolization for resectable large hepatocellular carcinoma (≥5 cm in diameter) , 2012, Journal of surgical oncology.

[22]  Lequn Li,et al.  Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  K. Okazaki,et al.  A Prospective Randomized Controlled Trial of Preoperative Whole-Liver Chemolipiodolization for Hepatocellular Carcinoma , 2012, Digestive Diseases and Sciences.

[24]  K. Sung,et al.  Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. , 2011, Journal of vascular and interventional radiology : JVIR.

[25]  J. Rui,et al.  Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  M. Koch,et al.  Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. , 2011, Surgery.

[27]  J. Belghiti,et al.  Oncologic Resection for Malignant Tumors of the Liver , 2011, Annals of surgery.

[28]  M. Koch,et al.  Hepatocellular Carcinoma: Current Management and Perspectives for the Future , 2011, Annals of surgery.

[29]  J. Llovet,et al.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.

[30]  C. Pan,et al.  Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  Minshan Chen,et al.  A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.

[32]  C. Ker,et al.  The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes , 2009, Journal of surgical oncology.

[33]  W. Lau,et al.  A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.

[34]  J. Rui,et al.  Edmondson-Steiner Grading Increases the Predictive Efficiency of TNM Staging for Long-term Survival of Patients with Hepatocellular Carcinoma After Curative Resection , 2008, World Journal of Surgery.

[35]  F. Farinati,et al.  Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness , 2008, The American Journal of Gastroenterology.

[36]  Wei Wei,et al.  [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[37]  D. Suh,et al.  Pre‐operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post‐operative patient outcome , 2007, Alimentary pharmacology & therapeutics.

[38]  J. Choi,et al.  Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma? , 2007, World Journal of Surgery.

[39]  C. Wai,et al.  Long Term Outcome and Prognostic Factors for Large Hepatocellular Carcinoma (10 cm or more) after Surgical Resection , 2007, Annals of Surgical Oncology.

[40]  Bixiang Zhang,et al.  Role of Mesohepatectomy with or without Transcatheter Arterial Chemoembolization for Large Centrally Located Hepatocellular Carcinoma , 2007, Digestive Surgery.

[41]  Y. Iwashita,et al.  Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[42]  O. Farges,et al.  The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.

[43]  Timothy M Pawlik,et al.  Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[44]  S. Futagawa,et al.  Role of Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: Relation between Postoperative Course and the Pattern of Tumor Recurrence , 2003, World Journal of Surgery.

[45]  H. Yamagishi,et al.  Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. , 2003, Hepato-gastroenterology.

[46]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[47]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[48]  S. Fan,et al.  Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. , 2002, Journal of the American College of Surgeons.

[49]  G. Gerunda,et al.  Role of transarterial chemoembolization before liver resection for hepatocarcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[50]  Guang-shun Yang,et al.  The effect of preoperative transcatheter hepatic arterial chemoembolization on disease‐free survival after hepatectomy for hepatocellular carcinoma , 1999, Cancer.

[51]  N. Tanigawa,et al.  Preoperative Transcatheter Arterial Chemoembolization and Prognosis of Patients with Hepatocellular Carcinomas: Retrospective Analysis of 120 Cases , 1999, World Journal of Surgery.

[52]  V. Vilgrain,et al.  Preoperative chemoembolization of hepatocellular carcinoma: a comparative study. , 1998, Archives of surgery.

[53]  H. Bismuth,et al.  Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. , 1997, Annals of surgery.

[54]  R. Yamada,et al.  Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer , 1995, World Journal of Surgery.

[55]  J. Sitzmann.  Conversion of unresectable to resectable liver cancer: An approach and follow-up study , 1995, World Journal of Surgery.

[56]  F. P'eng,et al.  Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal , 1995, The British journal of surgery.

[57]  M. Morino,et al.  Primary treatment of hepatocellular carcinoma by arterial chemoembolization. , 1992, American journal of surgery.

[58]  N. Nagasue,et al.  Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: A retrospective comparison of 138 liver resections , 1989, Surgery.

[59]  T. Wakasa,et al.  Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma. , 2013, International journal of oncology.

[60]  T. Wen,et al.  Risk factors of ascites after hepatectomy for patients with hepatocellular carcinoma and hepatitis B virus-associated cirrhosis. , 2012, Hepato-gastroenterology.

[61]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.